Close Menu

NEW YORK – Linear Diagnostics last week announced that it has received a £2 million ($2.6 million) investment.

The UK's Midlands Engine Investment Fund led the round, joined by the UK Innovation Science and Seed Fund, the University of Birmingham, Abingdon Health, and the firm's directors.

Linear Diagnostics, a spinout from the UK's University of Birmingham, plans to use the funds to develop its optical point-of-care diagnostic testing platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.